INSPIRE PHARMACEUTICALS INC - FORM 10-Q - EX-32.2 - SECTION 906 CFO CERTIFICATION - November 6, 2009

Attached files

file filename
10-Q - FORM 10-Q - INSPIRE PHARMACEUTICALS INCd10q.htm
EX-10.2 - TECHNOLOGY LICENSE AGREEMENT - INSPIRE PHARMACEUTICALS INCdex102.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - INSPIRE PHARMACEUTICALS INCdex321.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - INSPIRE PHARMACEUTICALS INCdex312.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - INSPIRE PHARMACEUTICALS INCdex311.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Inspire Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2009, as filed with the Securities and Exchange Commission (the “Report”), I, Thomas R. Staab, II, Chief Financial Officer & Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 6, 2009

  

/s/ Thomas R. Staab, II

 

Thomas R. Staab, II

 

Chief Financial Officer & Treasurer

(principal financial officer)

INSPIRE PHARMACEUTICALS INC Reports